Meanwhile, market cap of SKTO is ridiculously low (~$18m) -- despite coming blockbusters like Dharmanol, Dharmanol Citrolene and T-Hydrocan line; robust sales of established lines Yak and Yeti; massive California market penetration via over 400 collectives/dispensaries; and interstate plans for licenses and sales apparently taking shape.

Compare SKTO's absurdly low mc to some of these thin-air flyers with market caps in the hundreds of millions of dollars in some cases. Markets caps of that immense size are discounting net income (that has yet appear in nearly all cases) in monstrous measures for the next few years. Good luck with that.